$103 Million is the total value of Pettee Investors, Inc.'s 86 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XOM | Sell | Exxon Mobil | $7,760,000 | -2.2% | 93,268 | -0.1% | 7.55% | -1.9% |
| PFE | Sell | Pfizer | $5,891,000 | -3.6% | 175,685 | -0.0% | 5.73% | -3.3% |
| DIS | Sell | Disney | $3,142,000 | +8.6% | 27,530 | -0.2% | 3.06% | +8.9% |
| CLX | Sell | Clorox | $2,173,000 | -15.2% | 20,895 | -9.9% | 2.11% | -14.9% |
| SLB | Sell | Schlumberger | $1,797,000 | +3.0% | 20,853 | -0.2% | 1.75% | +3.4% |
| TRV | Exit | Travelers | $0 | – | -2,000 | -100.0% | -0.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Johnson & Johnson | 40 | Q3 2023 | 17.3% |
| JPMorgan Chase | 40 | Q3 2023 | 8.0% |
| Exxon Mobil | 40 | Q3 2023 | 9.3% |
| Pfizer | 40 | Q3 2023 | 6.0% |
| Procter & Gamble | 40 | Q3 2023 | 4.8% |
| Bristol-Myers Squibb | 40 | Q3 2023 | 4.1% |
| Nestle ADR | 40 | Q3 2023 | 3.4% |
| PepsiCo | 40 | Q3 2023 | 3.4% |
| Intel | 40 | Q3 2023 | 3.3% |
| Disney | 40 | Q3 2023 | 3.1% |
View Pettee Investors, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-10-20 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-05 |
| 13F-HR | 2023-01-25 |
| 13F-HR | 2022-11-09 |
| 13F-HR | 2022-07-25 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-02 |
View Pettee Investors, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.